Clinical Trial Update: Efficacy of Letrozole + Palbociclib Combination as Neoadjuvant Treatment of Stage II-IIIA PAM 50 ROR-defined Low or Intermediate Risk Luminal Breast Cancer, in Postmenopausal Women [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating letrozole plus palbociclib as neoadjuvant therapy for postmenopausal women with stage II-IIIA luminal breast cancer defined by PAM50 RO…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Luminal Breast Cancer

Drugs mentioned

• Letrozole (letrozole)
• Palbociclib (palbociclib)

Snippet

Sponsor: UNICANCER | Conditions: Neoadjuvant Operable Breast Cancer | Phase 2 | Status: COMPLETED